Mainly because variations from the cannabinoid receptor 1 (CNR1) gene and also the fatty acid amide hydrolase (FAAH) gene are connected with altered gut motility and feeling, Dr. Camilleri and colleagues also examined whether or not these genetic versions affected the participants' responses to therapy with CBD.The provision of such products varies